AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 41 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,268 | -61.2% | 3,744 | -58.7% | 0.00% | – |
| Q3 2022 | $11,000 | – | 9,068 | +2085.1% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 415 | -49.9% | 0.00% | – |
| Q1 2022 | $2,000 | -75.0% | 829 | -57.7% | 0.00% | – |
| Q4 2021 | $8,000 | -81.8% | 1,959 | -80.4% | 0.00% | – |
| Q3 2021 | $44,000 | -21.4% | 10,000 | -28.9% | 0.00% | – |
| Q2 2021 | $56,000 | -24.3% | 14,060 | -0.8% | 0.00% | – |
| Q1 2021 | $74,000 | -42.2% | 14,174 | -40.4% | 0.00% | – |
| Q4 2020 | $128,000 | +88.2% | 23,769 | +68.6% | 0.00% | – |
| Q3 2020 | $68,000 | -63.2% | 14,100 | -63.0% | 0.00% | – |
| Q2 2020 | $185,000 | +340.5% | 38,081 | +98.5% | 0.00% | – |
| Q1 2020 | $42,000 | -27.6% | 19,188 | +91.9% | 0.00% | – |
| Q4 2019 | $58,000 | +81.2% | 10,000 | 0.0% | 0.00% | – |
| Q3 2019 | $32,000 | -23.8% | 10,000 | 0.0% | 0.00% | – |
| Q2 2019 | $42,000 | -54.3% | 10,000 | -24.9% | 0.00% | – |
| Q1 2019 | $92,000 | +300.0% | 13,322 | +905.4% | 0.00% | – |
| Q3 2018 | $23,000 | – | 1,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $55,848,000 | 77.67% |
| Bracebridge Capital, LLC | 428,571 | $2,083,000 | 0.33% |
| Oak Grove Capital LLC | 89,000 | $432,000 | 0.20% |
| Perceptive Advisors | 1,750,000 | $8,496,000 | 0.12% |
| Virtu Financial LLC | 117,206 | $569,000 | 0.10% |
| WEDBUSH SECURITIES INC | 103,240 | $501,000 | 0.05% |
| J. Goldman & Co LP | 117,600 | $571,000 | 0.04% |
| Engineers Gate Manager LP | 68,300 | $332,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 118,900 | $577,000 | 0.01% |
| Brandywine Global Investment Management, LLC | 137,029 | $666,000 | 0.01% |